Aminoglycoside induced ototoxicity risk in the cystic fibrosis population: The utility of large‐scale screening-Reference-Cited by-同舟云学术

Aminoglycoside induced ototoxicity risk in the cystic fibrosis population: The utility of large‐scale screening

Published:2022-12-20 Issue:3 Volume:58 Page:819-824
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Lopes Jaime¹^ORCID,Vidal‐Folch Noemi²,Lundquist Patrick²,Schimmenti Lisa A.³,Demirel Nadir⁴,Dean Vicki⁴,Olson Janelle⁴,Auth Tom⁵,Butz Malinda²,Reed Katelyn⁵,Wylam Mark⁶^ORCID,Balcom Jessica²,Boczek Nicole J.²,Hasadsri Linda²

Affiliation:

1. Department of Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

2. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA

3. Department of Clinical Genomics Mayo Clinic Rochester Minnesota USA

4. Department of Pediatrics Mayo Clinic Rochester Minnesota USA

5. Department of Research Services Mayo Clinic Rochester Minnesota USA

6. Division of Pulmonary and Critical Care Medicine Mayo Clinic Rochester Minnesota USA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26259

Reference27 articles.

1. Aminoglycosides: An Overview

2. Interaction of Aminoglycosides with Human Mitochondrial 12S rRNA Carrying the Deafness-Associated Mutation

3. Cochlear implantation in a patient with profound hearing loss with the A1555G mitochondrial mutation;Tono T;Am J Otol,1998

4. Aminoglycoside-induced deafness during treatment of acute leukaemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of otorhinolaryngologic, audiologic, and genetic findings in children with cystic fibrosis: A tertiary care experience;Pediatric Pulmonology;2024-07-29

2. Assessment of Aminoglycoside-Induced Hearing Loss Risk in the Perinatal Period;American Journal of Perinatology;2024-07-15

3. Assessment of the risk of hearing loss in children with cystic fibrosis;Russian Bulletin of Otorhinolaryngology;2024